Class IIITerminatedD-0326-2017
Drug recall · January 11, 2017
TEMAZEPAM CAPSULES USP recall
Why: Failed Stability Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
TEMAZEPAM CAPSULES USP, 7.5 mg, 100 count bottles, Rx only, Manufactured for: QUALITEST PHARMACEUTICALS, HUNTSVILLE, AL 35811, NDC 0603-5891-21
- Lots / codes
T248H15A, Exp. 08/17
- Quantity
- 1200 bottles
- Company
- Vintage Pharmaceuticals LLC, DBA Qualitest Pharmaceuticals, Huntsville, AL
- Distribution
- Nationwide
- Initiated
- December 22, 2016 · Voluntary: Firm initiated
- Classified
- January 3, 2017
- Reported
- January 11, 2017
- Ended
- September 18, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Temazepam
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.